Cryptobiotix

Technologiepark-Zwijnaarde 82
9052 Gent
BE
Cryptobiotix
Foundation date
27/01/2021
Sector
#Biotechnology - otherSubsector
- #Therapeutics - Peptides
- #Therapeutics - Proteins
- #Therapeutics - Small molecules
- #Therapeutics - Vaccines
- #Other - Food
- #Other - Industrial Biotechnology
- #Other - Nutraceuticals
- #Pharma - Anti-infectives
- #Pharma - Gene therapy
- #Pharma - Generics
- #Pharma - Nucleic acid drugs
- #Pharma - Small molecule therapeutics
- #Pharma - Vaccines
Therapeutic areas
- #Cardiovascular
- #Conditions originating in the perinatal period
- #Digestive system
- #Neoplasms / cancer / oncology
- #Respiratory system
- #Skin and subcutaneous tissue
Preclinical CRO in the gastrointestinal space offering in vitro digestion and ex vivo gut microbiome research services. Cryptobiotix pushes the boundaries of preclinical gastrointestinal research with unparalleled throughput and biorelevance. From early R&D screening to in-depth characterisation of food products and therapeutics, we tailor your project to your research questions and provide you the data to accelerate and de-risk your product development.
Upcoming events
All events-
0310 '23
-
1810 '23
EMDS2023@VIB
Event by: VIB -
1212 '23
BioFIT 2023
Event by: Eurasanté
Latest news
More news-
argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis
Thursday September 21st 2023
Read more
-
Galapagos appoints Simon Sturge to its Board of Directors
Tuesday September 19th 2023
Read more
-
13th Investment for HERAN Partners: Broken String Biosciences (UK)
Tuesday September 19th 2023
Read more
Jobs
More jobs-
-
-
23/09/23
East Flanders
ERC-funded postdoc position on inter-organelle communication during plant biotic stress responses
Permanent
VIB